UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis

CNS spectrums, 2024-04, Vol.29 (2), p.150-154

2024

Volltextzugriff (PDF)

The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia

CNS spectrums, 2023-10, Vol.28 (5), p.541-560

2023

Volltextzugriff (PDF)

Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine

Annals of general psychiatry, 2024-02, Vol.23 (1), p.10-10, Article 10

2024

Volltextzugriff (PDF)

Free Energy Fluctuations of the Bipartite Spherical SK Model at Critical Temperature

Annales Henri Poincaré, 2024-05

2024

Volltextzugriff (PDF)

Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review

Physiology & behavior, 2024-09, Vol.283, p.114622, Article 114622

2024

Volltextzugriff (PDF)

Evaluating Anhedonia as a risk factor in suicidality: A meta-analysis

Journal of psychiatric research, 2023-02, Vol.158, p.209-215

2023

Volltextzugriff (PDF)

The role of KCNQ channel activators in management of major depressive disorder

Journal of affective disorders, 2024-08, Vol.359, p.364-372

2024

Volltextzugriff (PDF)

A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists

Journal of affective disorders, 2024-10, Vol.363, p.589-594

2024

Volltextzugriff (PDF)

Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial

Brain (London, England : 1878), 2024-03, Vol.147 (3), p.849-857

2024

Volltextzugriff (PDF)

Associations between somatic symptoms and remission of major depressive disorder: A longitudinal study in China

Journal of psychiatric research, 2024-04, Vol.172, p.382-390

2024

Volltextzugriff (PDF)

Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a post-hoc analysis: Anhedonia and psychosocial functioning in post-COVID-19 condition

Current medical research and opinion, 2024-08, Vol.40 (8), p.1407-1411

2024

Volltextzugriff (PDF)

Green Synthesis of Carbon Aerogel Derived from Lotus Root for the Removal of Ciprofloxacin, Oil, Organic Solvents, and Supercapacitor Applications

Water, air, and soil pollution, 2024-02, Vol.235 (2), p.135, Article 135

2024

Volltextzugriff (PDF)

Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic review

Journal of affective disorders, 2024-10, Vol.362, p.816-827

2024

Volltextzugriff (PDF)

Effects of cannabidiol and Δ 9 -tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review

Drug metabolism reviews, 2024-04, Vol.56 (2), p.164-174

2024

Volltextzugriff (PDF)

Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review

Drug metabolism reviews, 2024-04, Vol.56 (2), p.164-174

2024

Volltextzugriff (PDF)

Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis

Journal of affective disorders, 2024-07, Vol.356, p.684-698

2024

Volltextzugriff (PDF)

Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review

Journal of affective disorders, 2024-06, Vol.355, p.342-354

2024

Volltextzugriff (PDF)

A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review

Journal of affective disorders, 2024-04, Vol.350, p.698-705

2024

Volltextzugriff (PDF)

Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review

Journal of psychiatric research, 2023-08, Vol.164, p.80-89

2023

Volltextzugriff (PDF)

Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis

Psychiatry research, 2024-09, Vol.339, p.116068, Article 116068

2024

Volltextzugriff (PDF)

Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis

Journal of affective disorders, 2024-09, Vol.361, p.480-488

2024

Volltextzugriff (PDF)

Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials

Expert opinion on investigational drugs, 2023-05, Vol.32 (5), p.401-415

2023

Volltextzugriff (PDF)

Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis

Current medical research and opinion, 2024-07, Vol.40 (7), p.1203-1209

2024

Volltextzugriff (PDF)

Yeast cell as a potential microcapsule of bioactive compounds: an overview

Nutrire : revista de Sociedade Brasileira de Alimentação e Nutrição = journal of the Brazilian Society of Food and Nutrition, 2024-01, Vol.49 (1), p.12, Article 12

2024

Volltextzugriff (PDF)

Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review

Expert opinion on pharmacotherapy, 2024-03, Vol.25 (4), p.467-476

2024

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(41)

Publikationsform

Sprache

Englisch
(49)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis

The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia

Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine

Free Energy Fluctuations of the Bipartite Spherical SK Model at Critical Temperature

Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review

Evaluating Anhedonia as a risk factor in suicidality: A meta-analysis

The role of KCNQ channel activators in management of major depressive disorder

A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists

Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial

Associations between somatic symptoms and remission of major depressive disorder: A longitudinal study in China

Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a post-hoc analysis: Anhedonia and psychosocial functioning in post-COVID-19 condition

Green Synthesis of Carbon Aerogel Derived from Lotus Root for the Removal of Ciprofloxacin, Oil, Organic Solvents, and Supercapacitor Applications

Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic review

Effects of cannabidiol and Δ 9 -tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review

Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review

Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis

Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review

A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review

Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review

Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis

Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis

Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials

Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis

Yeast cell as a potential microcapsule of bioactive compounds: an overview

Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review

Suchergebnisse filtern